Cytek Biosciences, Inc. (CTKB): Revenue

Annual figures by period end, from SEC filings.

$201.49M
Year ended 2025-12-31
$206.71M
Trailing 12 months to 2026-06-30
+7.1%
3-year compound annual growth
+16.8%
5-year compound annual growth
2020-12-31: $92.84M2021-12-31: $127.95M2022-12-31: $164.04M2023-12-31: $193.01M2024-12-31: $200.45M2025-12-31: $201.49M$201.49M
2020-12-31 Revenue (USD) 2025-12-31
Period endedRevenueChange YoYSource filing
2025-12-31$201.49M+0.5%2026-02-26, From 2025-01-01
2024-12-31$200.45M+3.9%2026-02-26, From 2024-01-01
2023-12-31$193.01M+17.7%2026-02-26, From 2023-01-01
2022-12-31$164.04M+28.2%2025-02-28, From 2022-01-01
2021-12-31$127.95M+37.8%2024-03-13, From 2021-01-01
2020-12-31$92.84Mn/a2023-03-01, From 2020-01-01

Revenue at similar companies

Companies with the same SEC industry code (Laboratory Analytical Instruments), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedRevenueChange YoY
Cytek Biosciences, Inc. (CTKB)2025-12-31$201.49M+0.5%
Pacific Biosciences of California, Inc. (PACB)2025-12-31$160.00M+3.9%
Quanterix Corp (QTRX)2025-12-31$138.90M+1.1%
Harvard Bioscience Inc (HBIO)2025-12-31$86.55M-8.1%
10x Genomics, Inc. (TXG)2025-12-31$642.82M+5.2%
908 Devices Inc. (MASS)2025-12-31$56.20M+17.7%
Rapid Micro Biosystems, Inc. (RPID)2025-12-31$33.59M+19.7%
EyePoint, Inc. (EYPT)2025-12-31$31.37M-27.5%
Bionano Genomics, Inc. (BNGO)2025-12-31$28.51M-7.4%

Compare CTKB, PACB, QTRX, HBIO side by side · Screen every company in Laboratory Analytical Instruments ↗